Response to: Comparison of infliximab drug measurement across three commercially available ELISA kits: author reply

Affiliations

• ¹ University of NSW, Sydney, Australia; Sydney South West Pathology Service, Liverpool Hospital, Sydney, Australia. Electronic address: catherine.toong@sswahs.nsw.gov.au.
• ² Department of Immunology, Liverpool Hospital, Sydney, (currently practising at Immunology Department, Campbelltown Hospital, Campbelltown), Australia.
• ³ University of NSW, Sydney, Australia; Department of Gastroenterology and Hepatology, Liverpool Hospital, Sydney, NSW, Australia.
• ⁴ Department of Gastroenterology and Hepatology, Liverpool Hospital, Sydney, NSW, Australia.